Holen Sie sich die Stockscreener-App
43.88
3.39%
1.44
Handel nachbörslich:
44.00
0.12
+0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Harrow Inc Aktie (HROW) Neueste Nachrichten
Harrow subsidiary wins $34.9 million in trademark case - Investing.com
Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com UK
Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX | HROW Stock News - StockTitan
HROW (Harrow) Capex-to-Operating-Cash-Flow : 0.20 (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Receivables : $-35.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com
HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com
Former Harrow unit Melt announces results for MELT-300 to sedate for surgery - TipRanks
First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat
Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat
Harrow Announces Participation in Upcoming Investor Conferences - BioSpace
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey
Harrow to Present at Major Healthcare Conferences, Including Piper Sandler's Annual Event | HROW Stock News - StockTitan
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy
Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday
Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks
Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Q3 2024 Harrow Inc Earnings Call Transcript - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings: Revenue at $49.3M, Misses Es - GuruFocus.com
Los Angeles Capital Management LLC Sells 38,168 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow: Q3 Earnings Snapshot - New Haven Register
Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN
Harrow stock plunges 20% on weaker-than-expected Q3 earnings (NASDAQ:HROW) - Seeking Alpha
Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
HROWHarrow, Inc. Latest Stock News & Market Updates - StockTitan
Harrow Q3 Revenue Surges 44% to $49.3M as VEVYE Prescriptions Jump 55% | HROW Stock News - StockTitan
Harrow Inc (HROW) Shares Up 6.99% on Nov 13 - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Harrow Partners with GoodRx, Cuts Prices on Key Eye Drug Portfolio | HROW Stock News - StockTitan
Harrow secures Medicare coverage for dry eye treatment VEVYE By Investing.com - Investing.com Canada
Harrow Inc (HROW) Stock Price Down 3.18% on Nov 12 - GuruFocus.com
Earnings Outlook For Harrow - Benzinga
Harrow secures Medicare coverage for dry eye treatment VEVYE - Investing.com India
Harrow Announces Market Access Wins for VEVYE® - Business Wire
Harrow's VEVYE Secures Major Medicare Coverage, Reaching 25M+ Beneficiaries in 2025 | HROW Stock News - StockTitan
Harrow: VEVYE And Its Impact On The DED Market (NASDAQ:HROW) - Seeking Alpha
Equitable Trust Co. Has $2.62 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Woodmont Investment Counsel LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products - Business Wire
Best Momentum Stocks To Buy For November 6th - Barchart
Will Harrow (HROW) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Harrow (HROW) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
Imprimis Pharmaceuticals, Inc. announced that it has received $3 million in funding from Immy Funding LLC. - Marketscreener.com
Harrow, Inc. (NASDAQ:HROW) Shares Purchased by Rice Hall James & Associates LLC - MarketBeat
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024 - BioSpace
1.01%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):